Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision has been updated to v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now lists Revision: v3.4.2 in the footer, replacing the previous Revision: v3.4.1. No other content or functionality appears to be affected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision indicator updated from v3.4.0 to v3.4.1. No other visible content changes were detected.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.4.1 replacing Revision: v3.4.0; this is a minor administrative update and does not affect trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedShow glossary toggle has been added, along with new metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision 'v3.4.0'. The old labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.